Insider Transactions in Q2 2024 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
Amy W Schulman Director |
SELL
Open market or private sale
|
Direct |
8,500
-50.19%
|
$2,040,000
$240.0 P/Share
|
|
Jun 25
2024
|
Amy W Schulman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+33.42%
|
$1,113,500
$131.21 P/Share
|
|
Jun 25
2024
|
Kevin Joseph Fitzgerald CSO & EVP, Head of Research |
SELL
Open market or private sale
|
Direct |
1,198
-0.67%
|
$274,342
$229.42 P/Share
|
|
Jun 25
2024
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,605
-1.07%
|
$367,545
$229.42 P/Share
|
|
Jun 25
2024
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,605
-0.45%
|
$367,545
$229.42 P/Share
|
|
Jun 25
2024
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,301
-0.81%
|
$1,900,929
$229.42 P/Share
|
|
Jun 25
2024
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
2,103
-1.05%
|
$481,587
$229.42 P/Share
|
|
Jun 24
2024
|
Kevin Joseph Fitzgerald CSO & EVP, Head of Research |
BUY
Grant, award, or other acquisition
|
Direct |
2,498
+13.97%
|
-
|
|
Jun 24
2024
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,278
+19.82%
|
-
|
|
Jun 24
2024
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,278
+9.71%
|
-
|
|
Jun 24
2024
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,953
+16.03%
|
-
|
|
Jun 24
2024
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
4,295
+19.52%
|
-
|
|
Jun 24
2024
|
David E I Pyott Director |
SELL
Open market or private sale
|
Direct |
32,450
-67.16%
|
$7,171,450
$221.0 P/Share
|
|
Jun 24
2024
|
David E I Pyott Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,450
+30.42%
|
$2,498,650
$77.05 P/Share
|
|
May 29
2024
|
Amy W Schulman Director |
SELL
Open market or private sale
|
Direct |
21,700
-30.62%
|
$3,211,600
$148.97 P/Share
|
|
May 29
2024
|
Amy W Schulman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.89%
|
$1,980,000
$66.83 P/Share
|